A detailed history of Nebula Research & Development LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 13,439 shares of KROS stock, worth $228,866. This represents 0.09% of its overall portfolio holdings.

Number of Shares
13,439
Previous 8,254 62.82%
Holding current value
$228,866
Previous $377 Million 106.89%
% of portfolio
0.09%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$41.68 - $58.07 $216,110 - $301,092
5,185 Added 62.82%
13,439 $780 Million
Q2 2024

Aug 14, 2024

BUY
$44.58 - $66.89 $367,963 - $552,110
8,254 New
8,254 $377 Million

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $439M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.